Abstract
Despite the advances in the field of stem cell transplantation, relapse remains a major source of mortality. CIBMTR data identify relapse as the cause of death in 78% of autologous transplant patients, 34% of related allogeneic transplant patients, and 23% of unrelated transplant patients. With the advent of reduced intensity transplants allowing more patients to proceed with transplant, there have been reports of higher than anticipated relapses. Management of relapse post-transplant requires assessment of multiple host/recipient factors and often is limited by the compromised status of the recipient.
Original language | English (US) |
---|---|
Title of host publication | Blood and Marrow Transplant Handbook |
Subtitle of host publication | Comprehensive Guide for Patient Care |
Publisher | Springer New York |
Pages | 271-276 |
Number of pages | 6 |
ISBN (Print) | 9781441975058 |
DOIs | |
State | Published - 2011 |
ASJC Scopus subject areas
- Medicine(all)